KAFTRIO (elexacaftor/tezacaftor/ivacaftor) Tablets

KAFTRIO is a prescription medicine used to treat cystic fibrosis (CF). FDA approved elexacaftor/tezacaftor/ivacaftor (brand name KAFTRIO) is not (yet) registered or available in India but on request Indian patient can buy KAFTRIO at the lowest price.

KAFTRIO (elexacaftor/elexacaftor/tezacaftor/ivacaftor) Tablets Price In Delhi India Ahmedabad Bengaluru Chennai Kolkata Mumbai
KAFTRIO (elexacaftor/tezacaftor/ivacaftor) Tablets

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

KAFTRIO (elexacaftor/tezacaftor/ivacaftor) Tablets

Fruquintinib is indicated for adults with metastatic colorectal cancer who received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.

Kaftrio tablets are indicated in a combination regimen with ivacaftor for the treatment of cystic
fibrosis (CF) in patients aged 6 years and older who have at least one F508del mutation in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene.

TRIKAFTA adds elexacaftor to tezacaftor and ivacaftor to target CFTR protein defects caused by the F508del mutation or another mutation responsive to TRIKAFTA. Together, the 3 components help responsive CFTR proteins function better.

Drug Brand Name: Kaftrio 37.5 mg/25 mg/50 mg film-coated tablets
Strength:
Kaftrio 37.5 mg/25 mg/50 mg film-coated tablets
Kaftrio 75 mg/50 mg/100 mg film-coated tablets

Current Indication: Treat cystic fibrosis (CF)
Marketed By: Vertex Φαρμακευτική Μονοπρόσωπη Ανώνυμη
Approval Date: : On 11 January 2022

Kaftrio 37.5 mg/25 mg/50 mg film-coated tablets
Kaftrio 75 mg/50 mg/100 mg film-coated tablets

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.